Clinical Trial

Changes in Eye Pressure in Glaucoma Patients Treated with Istent Inject W, Monitored by a Contact Lens Sensor

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 6, 2025 (before its estimated October 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to compare the IOP-related fluctuations using the CLS (contact lens sensor) Sensimed Triggerfish in glaucoma patients before and after glaucoma surgery with iStent inject W under physiological conditions and compare these results with a control group of glaucoma patients treated only with hypotensive medical treatment requiring cataract surgery.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-09-18; most recent amendment 2025-03-04.
Status change: Not Yet Recruiting → Recruiting 2025-03-04
Trial Details
NCT Number NCT06607705
Lead Sponsor Fundacio Privada Mon Clinic Barcelona
Collaborators: Glaukos Corporation
Conditions Glaucoma Eye
Enrollment 53 participants
Start Date 2024-10-21
Primary Completion 2025-10-01 (estimated)
Study Completion 2025-10-01 (estimated)
Updated on ClinicalTrials.gov 2025-03-06